APO Research
Talk to an analyst

APO RESEARCH · REPORT

OTC Anti-Infective Products

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global OTC Anti-Infective Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

29 December 2025194 pages

Choose your research edition.

Industry ResearchOTC Anti-Infective Products Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal OTC Anti-Infective Products Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal OTC Anti-Infective Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal OTC Anti-Infective Products Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal OTC Anti-Infective Products Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global OTC Anti-Infective Products market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for OTC Anti-Infective Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for OTC Anti-Infective Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for OTC Anti-Infective Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for OTC Anti-Infective Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of OTC Anti-Infective Products include Teva, Johnson & Johnson, NOVARTIS, MYLAN, Roche, Lingrui, Pfizer, CR SANJIU and GSK, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global OTC Anti-Infective Products market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of OTC Anti-Infective Products and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents OTC Anti-Infective Products sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the OTC Anti-Infective Products market size, projected growth trends, production technologies, key applications, and end-use industries.

OTC Anti-Infective Products Segment by Company

Teva

Johnson & Johnson

NOVARTIS

MYLAN

Roche

Lingrui

Pfizer

CR SANJIU

GSK

Bayer

Sun Pharma

Gilead Sciences

Cipla

Bausch Health

Astellas Pharma

OTC Anti-Infective Products Segment by Type

Antiviral

Antibacterial

Antifungal

Antiseptics

Others

OTC Anti-Infective Products Segment by Application

Retail Pharmacies

Online Pharmacies

Hospital Pharmacies

OTC Anti-Infective Products Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global OTC Anti-Infective Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of OTC Anti-Infective Products and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of OTC Anti-Infective Products.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the OTC Anti-Infective Products market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of OTC Anti-Infective Products manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of OTC Anti-Infective Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of OTC Anti-Infective Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. OTC Anti-Infective Products Industry Trends Table 2. OTC Anti-Infective Products Industry Drivers Table 3. OTC Anti-Infective Products Industry Opportunities and Challenges Table 4. OTC Anti-Infective Products Industry Restraints Table 5. Global OTC Anti-Infective Products Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global OTC Anti-Infective Products Revenue Market Share by Manufacturers (2021-2026) Table 7. Global OTC Anti-Infective Products Sales by Manufacturers (M Units) & (2021-2026) Table 8. Global OTC Anti-Infective Products Sales Market Share by Manufacturers Table 9. Global OTC Anti-Infective Products Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global OTC Anti-Infective Products Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global OTC Anti-Infective Products Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global OTC Anti-Infective Products Manufacturers, Product Type & Application Table 13. Global OTC Anti-Infective Products Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global OTC Anti-Infective Products by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Antiviral Table 17. Major Manufacturers of Antibacterial Table 18. Major Manufacturers of Antifungal Table 19. Major Manufacturers of Antiseptics Table 20. Major Manufacturers of Others Table 21. Global OTC Anti-Infective Products Sales by Type 2021 VS 2025 VS 2032 (M Units) Table 22. Global OTC Anti-Infective Products Sales by Type (2021-2026) & (M Units) Table 23. Global OTC Anti-Infective Products Sales by Type (2027-2032) & (M Units) Table 24. Global OTC Anti-Infective Products Sales Market Share by Type (2021-2026) Table 25. Global OTC Anti-Infective Products Sales Market Share by Type (2027-2032) Table 26. Global OTC Anti-Infective Products Revenue by Type 2021 VS 2025 VS 2032 (M Units) Table 27. Global OTC Anti-Infective Products Revenue by Type (2021-2026) & (M Units) Table 28. Global OTC Anti-Infective Products Revenue by Type (2027-2032) & (M Units) Table 29. Global OTC Anti-Infective Products Revenue Market Share by Type (2021-2026) Table 30. Global OTC Anti-Infective Products Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Retail Pharmacies Table 32. Major Manufacturers of Online Pharmacies Table 33. Major Manufacturers of Hospital Pharmacies Table 34. Global OTC Anti-Infective Products Sales by Application 2021 VS 2025 VS 2032 (M Units) Table 35. Global OTC Anti-Infective Products Sales by Application (2021-2026) & (M Units) Table 36. Global OTC Anti-Infective Products Sales by Application (2027-2032) & (M Units) Table 37. Global OTC Anti-Infective Products Sales Market Share by Application (2021-2026) Table 38. Global OTC Anti-Infective Products Sales Market Share by Application (2027-2032) Table 39. Global OTC Anti-Infective Products Revenue by Application 2021 VS 2025 VS 2032 (M Units) Table 40. Global OTC Anti-Infective Products Revenue by Application (2021-2026) & (M Units) Table 41. Global OTC Anti-Infective Products Revenue by Application (2027-2032) & (M Units) Table 42. Global OTC Anti-Infective Products Revenue Market Share by Application (2021-2026) Table 43. Global OTC Anti-Infective Products Revenue Market Share by Application (2027-2032) Table 44. Global OTC Anti-Infective Products Sales by Region: 2021 VS 2025 VS 2032 (M Units) Table 45. Global OTC Anti-Infective Products Sales by Region (2021-2026) & (M Units) Table 46. Global OTC Anti-Infective Products Sales Market Share by Region (2021-2026) Table 47. Global OTC Anti-Infective Products Sales Forecasted by Region (2027-2032) & (M Units) Table 48. Global OTC Anti-Infective Products Sales Forecasted Market Share by Region (2027-2032) Table 49. North America OTC Anti-Infective Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 50. North America OTC Anti-Infective Products Sales by Country (2021-2026) & (M Units) Table 51. North America OTC Anti-Infective Products Sales by Country (2027-2032) & (M Units) Table 52. Europe OTC Anti-Infective Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 53. Europe OTC Anti-Infective Products Sales by Country (2021-2026) & (M Units) Table 54. Europe OTC Anti-Infective Products Sales by Country (2027-2032) & (M Units) Table 55. Asia Pacific OTC Anti-Infective Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 56. Asia Pacific OTC Anti-Infective Products Sales by Country (2021-2026) & (M Units) Table 57. Asia Pacific OTC Anti-Infective Products Sales by Country (2027-2032) & (M Units) Table 58. South America, Middle East and Africa OTC Anti-Infective Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 59. South America, Middle East and Africa OTC Anti-Infective Products Sales by Country (2021-2026) & (M Units) Table 60. South America, Middle East and Africa OTC Anti-Infective Products Sales by Country (2027-2032) & (M Units) Table 61. Global OTC Anti-Infective Products Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global OTC Anti-Infective Products Revenue by Region (2021-2026) & (US$ Million) Table 63. Global OTC Anti-Infective Products Revenue by Region (2027-2032) & (US$ Million) Table 64. Global OTC Anti-Infective Products Revenue Market Share by Region (2021-2026) Table 65. Global OTC Anti-Infective Products Revenue Market Share by Region (2027-2032) Table 66. Teva Company Information Table 67. Teva Business Overview Table 68. Teva OTC Anti-Infective Products Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Teva OTC Anti-Infective Products Product Portfolio Table 70. Teva Recent Development Table 71. Johnson & Johnson Company Information Table 72. Johnson & Johnson Business Overview Table 73. Johnson & Johnson OTC Anti-Infective Products Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Johnson & Johnson OTC Anti-Infective Products Product Portfolio Table 75. Johnson & Johnson Recent Development Table 76. NOVARTIS Company Information Table 77. NOVARTIS Business Overview Table 78. NOVARTIS OTC Anti-Infective Products Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. NOVARTIS OTC Anti-Infective Products Product Portfolio Table 80. NOVARTIS Recent Development Table 81. MYLAN Company Information Table 82. MYLAN Business Overview Table 83. MYLAN OTC Anti-Infective Products Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. MYLAN OTC Anti-Infective Products Product Portfolio Table 85. MYLAN Recent Development Table 86. Roche Company Information Table 87. Roche Business Overview Table 88. Roche OTC Anti-Infective Products Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Roche OTC Anti-Infective Products Product Portfolio Table 90. Roche Recent Development Table 91. Lingrui Company Information Table 92. Lingrui Business Overview Table 93. Lingrui OTC Anti-Infective Products Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Lingrui OTC Anti-Infective Products Product Portfolio Table 95. Lingrui Recent Development Table 96. Pfizer Company Information Table 97. Pfizer Business Overview Table 98. Pfizer OTC Anti-Infective Products Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Pfizer OTC Anti-Infective Products Product Portfolio Table 100. Pfizer Recent Development Table 101. CR SANJIU Company Information Table 102. CR SANJIU Business Overview Table 103. CR SANJIU OTC Anti-Infective Products Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. CR SANJIU OTC Anti-Infective Products Product Portfolio Table 105. CR SANJIU Recent Development Table 106. GSK Company Information Table 107. GSK Business Overview Table 108. GSK OTC Anti-Infective Products Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. GSK OTC Anti-Infective Products Product Portfolio Table 110. GSK Recent Development Table 111. Bayer Company Information Table 112. Bayer Business Overview Table 113. Bayer OTC Anti-Infective Products Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. Bayer OTC Anti-Infective Products Product Portfolio Table 115. Bayer Recent Development Table 116. Sun Pharma Company Information Table 117. Sun Pharma Business Overview Table 118. Sun Pharma OTC Anti-Infective Products Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 119. Sun Pharma OTC Anti-Infective Products Product Portfolio Table 120. Sun Pharma Recent Development Table 121. Gilead Sciences Company Information Table 122. Gilead Sciences Business Overview Table 123. Gilead Sciences OTC Anti-Infective Products Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 124. Gilead Sciences OTC Anti-Infective Products Product Portfolio Table 125. Gilead Sciences Recent Development Table 126. Cipla Company Information Table 127. Cipla Business Overview Table 128. Cipla OTC Anti-Infective Products Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 129. Cipla OTC Anti-Infective Products Product Portfolio Table 130. Cipla Recent Development Table 131. Bausch Health Company Information Table 132. Bausch Health Business Overview Table 133. Bausch Health OTC Anti-Infective Products Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 134. Bausch Health OTC Anti-Infective Products Product Portfolio Table 135. Bausch Health Recent Development Table 136. Astellas Pharma Company Information Table 137. Astellas Pharma Business Overview Table 138. Astellas Pharma OTC Anti-Infective Products Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 139. Astellas Pharma OTC Anti-Infective Products Product Portfolio Table 140. Astellas Pharma Recent Development Table 141. Key Raw Materials Table 142. Raw Materials Key Suppliers Table 143. OTC Anti-Infective Products Distributors List Table 144. OTC Anti-Infective Products Customers List Table 145. Research Programs/Design for This Report Table 146. Authors List of This Report Table 147. Secondary Sources Table 148. Primary Sources List of Figures Figure 1. OTC Anti-Infective Products Product Image Figure 2. Global OTC Anti-Infective Products Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global OTC Anti-Infective Products Market Size (2021-2032) & (US$ Million) Figure 4. Global OTC Anti-Infective Products Sales (2021-2032) & (M Units) Figure 5. Global OTC Anti-Infective Products Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 OTC Anti-Infective Products Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Antiviral Image Figure 9. Antibacterial Image Figure 10. Antifungal Image Figure 11. Antiseptics Image Figure 12. Others Image Figure 13. Global OTC Anti-Infective Products Sales by Type (2021 VS 2025 VS 2032) & (M Units) Figure 14. Global OTC Anti-Infective Products Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global OTC Anti-Infective Products Sales Market Share by Type (2021-2032) Figure 16. Global OTC Anti-Infective Products Revenue by Type (2021 VS 2025 VS 2032) & (M Units) Figure 17. Global OTC Anti-Infective Products Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global OTC Anti-Infective Products Revenue Market Share by Type (2021-2032) Figure 19. Retail Pharmacies Image Figure 20. Online Pharmacies Image Figure 21. Hospital Pharmacies Image Figure 22. Global OTC Anti-Infective Products Sales by Application (2021 VS 2025 VS 2032) & (M Units) Figure 23. Global OTC Anti-Infective Products Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global OTC Anti-Infective Products Sales Market Share by Application (2021-2032) Figure 25. Global OTC Anti-Infective Products Revenue by Application (2021 VS 2025 VS 2032) & (M Units) Figure 26. Global OTC Anti-Infective Products Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global OTC Anti-Infective Products Revenue Market Share by Application (2021-2032) Figure 28. North America OTC Anti-Infective Products Sales and Growth Rate (2021-2032) & (M Units) Figure 29. North America OTC Anti-Infective Products Sales Market Share by Country (2021-2032) Figure 30. U.S. OTC Anti-Infective Products Sales and Growth Rate (2021-2032) & (M Units) Figure 31. Canada OTC Anti-Infective Products Sales and Growth Rate (2021-2032) & (M Units) Figure 32. Mexico OTC Anti-Infective Products Sales and Growth Rate (2021-2032) & (M Units) Figure 33. Europe OTC Anti-Infective Products Sales and Growth Rate (2021-2032) & (M Units) Figure 34. Europe OTC Anti-Infective Products Sales Market Share by Country (2021-2032) Figure 35. Germany OTC Anti-Infective Products Sales and Growth Rate (2021-2032) & (M Units) Figure 36. France OTC Anti-Infective Products Sales and Growth Rate (2021-2032) & (M Units) Figure 37. U.K. OTC Anti-Infective Products Sales and Growth Rate (2021-2032) & (M Units) Figure 38. Italy OTC Anti-Infective Products Sales and Growth Rate (2021-2032) & (M Units) Figure 39. Netherlands OTC Anti-Infective Products Sales and Growth Rate (2021-2032) & (M Units) Figure 40. Asia Pacific OTC Anti-Infective Products Sales and Growth Rate (2021-2032) & (M Units) Figure 41. Asia Pacific OTC Anti-Infective Products Sales Market Share by Country (2021-2032) Figure 42. China OTC Anti-Infective Products Sales and Growth Rate (2021-2032) & (M Units) Figure 43. Japan OTC Anti-Infective Products Sales and Growth Rate (2021-2032) & (M Units) Figure 44. South Korea OTC Anti-Infective Products Sales and Growth Rate (2021-2032) & (M Units) Figure 45. Southeast Asia OTC Anti-Infective Products Sales and Growth Rate (2021-2032) & (M Units) Figure 46. India OTC Anti-Infective Products Sales and Growth Rate (2021-2032) & (M Units) Figure 47. Australia OTC Anti-Infective Products Sales and Growth Rate (2021-2032) & (M Units) Figure 48. South America, Middle East and Africa OTC Anti-Infective Products Sales and Growth Rate (2021-2032) & (M Units) Figure 49. South America, Middle East and Africa OTC Anti-Infective Products Sales Market Share by Country (2021-2032) Figure 50. Brazil OTC Anti-Infective Products Sales and Growth Rate (2021-2032) & (M Units) Figure 51. South Africa OTC Anti-Infective Products Sales and Growth Rate (2021-2032) & (M Units) Figure 52. Saudi Arabia OTC Anti-Infective Products Sales and Growth Rate (2021-2032) & (M Units) Figure 53. Turkey OTC Anti-Infective Products Sales and Growth Rate (2021-2032) & (M Units) Figure 54. Argentina OTC Anti-Infective Products Sales and Growth Rate (2021-2032) & (M Units) Figure 55. UAE OTC Anti-Infective Products Sales and Growth Rate (2021-2032) & (M Units) Figure 56. Egypt OTC Anti-Infective Products Sales and Growth Rate (2021-2032) & (M Units) Figure 57. Chile OTC Anti-Infective Products Sales and Growth Rate (2021-2032) & (M Units) Figure 58. Global OTC Anti-Infective Products Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global OTC Anti-Infective Products Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America OTC Anti-Infective Products Revenue (2021-2032) & (US$ Million) Figure 61. North America OTC Anti-Infective Products Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe OTC Anti-Infective Products Revenue (2021-2032) & (US$ Million) Figure 63. Europe OTC Anti-Infective Products Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific OTC Anti-Infective Products Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific OTC Anti-Infective Products Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa OTC Anti-Infective Products Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa OTC Anti-Infective Products Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. OTC Anti-Infective Products Value Chain Figure 69. Manufacturing Cost Structure Figure 70. OTC Anti-Infective Products Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Antiviral
  • Antibacterial
  • Antifungal
  • Antiseptics
  • Others
Applications
  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies
Companies covered
  • Teva
  • Johnson & Johnson
  • NOVARTIS
  • MYLAN
  • Roche
  • Lingrui
  • Pfizer
  • CR SANJIU
  • GSK
  • Bayer
  • Sun Pharma
  • Gilead Sciences
  • Cipla
  • Bausch Health
  • Astellas Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global OTC Anti-Infective Products Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global OTC Anti-Infective Products Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global OTC Anti-Infective Products Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global OTC Anti-Infective Products Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global OTC Anti-Infective Products Market Dynamics
  1. 2.1 OTC Anti-Infective Products Industry Trends
  2. 2.2 OTC Anti-Infective Products Industry Drivers
  3. 2.3 OTC Anti-Infective Products Industry Opportunities and Challenges
  4. 2.4 OTC Anti-Infective Products Industry Restraints
3 OTC Anti-Infective Products Market by Manufacturers
  1. 3.1 Global OTC Anti-Infective Products Revenue by Manufacturers (2021-2026)
  2. 3.2 Global OTC Anti-Infective Products Sales by Manufacturers (2021-2026)
  3. 3.3 Global OTC Anti-Infective Products Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global OTC Anti-Infective Products Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global OTC Anti-Infective Products Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global OTC Anti-Infective Products Manufacturers, Product Type & Application
  7. 3.7 Global OTC Anti-Infective Products Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global OTC Anti-Infective Products Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 OTC Anti-Infective Products Players Market Share by Revenue in 2025
  11. 3.8.3 2025 OTC Anti-Infective Products Tier 1, Tier 2, and Tier 3
4 OTC Anti-Infective Products Market by Type
  1. 4.1 OTC Anti-Infective Products Type Introduction
  2. 4.1.1 Antiviral
  3. 4.1.2 Antibacterial
  4. 4.1.3 Antifungal
  5. 4.1.4 Antiseptics
  6. 4.1.5 Others
  7. 4.2 Global OTC Anti-Infective Products Sales by Type
  8. 4.2.1 Global OTC Anti-Infective Products Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global OTC Anti-Infective Products Sales by Type (2021-2032)
  10. 4.2.3 Global OTC Anti-Infective Products Sales Market Share by Type (2021-2032)
  11. 4.3 Global OTC Anti-Infective Products Revenue by Type
  12. 4.3.1 Global OTC Anti-Infective Products Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global OTC Anti-Infective Products Revenue by Type (2021-2032)
  14. 4.3.3 Global OTC Anti-Infective Products Revenue Market Share by Type (2021-2032)
5 OTC Anti-Infective Products Market by Application
  1. 5.1 OTC Anti-Infective Products Application Introduction
  2. 5.1.1 Retail Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Hospital Pharmacies
  5. 5.2 Global OTC Anti-Infective Products Sales by Application
  6. 5.2.1 Global OTC Anti-Infective Products Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global OTC Anti-Infective Products Sales by Application (2021-2032)
  8. 5.2.3 Global OTC Anti-Infective Products Sales Market Share by Application (2021-2032)
  9. 5.3 Global OTC Anti-Infective Products Revenue by Application
  10. 5.3.1 Global OTC Anti-Infective Products Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global OTC Anti-Infective Products Revenue by Application (2021-2032)
  12. 5.3.3 Global OTC Anti-Infective Products Revenue Market Share by Application (2021-2032)
6 Global OTC Anti-Infective Products Sales by Region
  1. 6.1 Global OTC Anti-Infective Products Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global OTC Anti-Infective Products Sales by Region (2021-2032)
  3. 6.2.1 Global OTC Anti-Infective Products Sales by Region (2021-2026)
  4. 6.2.2 Global OTC Anti-Infective Products Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America OTC Anti-Infective Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America OTC Anti-Infective Products Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe OTC Anti-Infective Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe OTC Anti-Infective Products Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific OTC Anti-Infective Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific OTC Anti-Infective Products Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa OTC Anti-Infective Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa OTC Anti-Infective Products Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global OTC Anti-Infective Products Revenue by Region
  1. 7.1 Global OTC Anti-Infective Products Revenue by Region
  2. 7.1.1 Global OTC Anti-Infective Products Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global OTC Anti-Infective Products Revenue by Region (2021-2026)
  4. 7.1.3 Global OTC Anti-Infective Products Revenue by Region (2027-2032)
  5. 7.1.4 Global OTC Anti-Infective Products Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America OTC Anti-Infective Products Revenue (2021-2032)
  8. 7.2.2 North America OTC Anti-Infective Products Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe OTC Anti-Infective Products Revenue (2021-2032)
  11. 7.3.2 Europe OTC Anti-Infective Products Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific OTC Anti-Infective Products Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific OTC Anti-Infective Products Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa OTC Anti-Infective Products Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa OTC Anti-Infective Products Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva
  2. 8.1.1 Teva Company Information
  3. 8.1.2 Teva Business Overview
  4. 8.1.3 Teva OTC Anti-Infective Products Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva OTC Anti-Infective Products Product Portfolio
  6. 8.1.5 Teva Recent Developments
  7. 8.2 Johnson & Johnson
  8. 8.2.1 Johnson & Johnson Company Information
  9. 8.2.2 Johnson & Johnson Business Overview
  10. 8.2.3 Johnson & Johnson OTC Anti-Infective Products Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Johnson & Johnson OTC Anti-Infective Products Product Portfolio
  12. 8.2.5 Johnson & Johnson Recent Developments
  13. 8.3 NOVARTIS
  14. 8.3.1 NOVARTIS Company Information
  15. 8.3.2 NOVARTIS Business Overview
  16. 8.3.3 NOVARTIS OTC Anti-Infective Products Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 NOVARTIS OTC Anti-Infective Products Product Portfolio
  18. 8.3.5 NOVARTIS Recent Developments
  19. 8.4 MYLAN
  20. 8.4.1 MYLAN Company Information
  21. 8.4.2 MYLAN Business Overview
  22. 8.4.3 MYLAN OTC Anti-Infective Products Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 MYLAN OTC Anti-Infective Products Product Portfolio
  24. 8.4.5 MYLAN Recent Developments
  25. 8.5 Roche
  26. 8.5.1 Roche Company Information
  27. 8.5.2 Roche Business Overview
  28. 8.5.3 Roche OTC Anti-Infective Products Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Roche OTC Anti-Infective Products Product Portfolio
  30. 8.5.5 Roche Recent Developments
  31. 8.6 Lingrui
  32. 8.6.1 Lingrui Company Information
  33. 8.6.2 Lingrui Business Overview
  34. 8.6.3 Lingrui OTC Anti-Infective Products Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Lingrui OTC Anti-Infective Products Product Portfolio
  36. 8.6.5 Lingrui Recent Developments
  37. 8.7 Pfizer
  38. 8.7.1 Pfizer Company Information
  39. 8.7.2 Pfizer Business Overview
  40. 8.7.3 Pfizer OTC Anti-Infective Products Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Pfizer OTC Anti-Infective Products Product Portfolio
  42. 8.7.5 Pfizer Recent Developments
  43. 8.8 CR SANJIU
  44. 8.8.1 CR SANJIU Company Information
  45. 8.8.2 CR SANJIU Business Overview
  46. 8.8.3 CR SANJIU OTC Anti-Infective Products Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 CR SANJIU OTC Anti-Infective Products Product Portfolio
  48. 8.8.5 CR SANJIU Recent Developments
  49. 8.9 GSK
  50. 8.9.1 GSK Company Information
  51. 8.9.2 GSK Business Overview
  52. 8.9.3 GSK OTC Anti-Infective Products Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 GSK OTC Anti-Infective Products Product Portfolio
  54. 8.9.5 GSK Recent Developments
  55. 8.10 Bayer
  56. 8.10.1 Bayer Company Information
  57. 8.10.2 Bayer Business Overview
  58. 8.10.3 Bayer OTC Anti-Infective Products Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Bayer OTC Anti-Infective Products Product Portfolio
  60. 8.10.5 Bayer Recent Developments
  61. 8.11 Sun Pharma
  62. 8.11.1 Sun Pharma Company Information
  63. 8.11.2 Sun Pharma Business Overview
  64. 8.11.3 Sun Pharma OTC Anti-Infective Products Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Sun Pharma OTC Anti-Infective Products Product Portfolio
  66. 8.11.5 Sun Pharma Recent Developments
  67. 8.12 Gilead Sciences
  68. 8.12.1 Gilead Sciences Company Information
  69. 8.12.2 Gilead Sciences Business Overview
  70. 8.12.3 Gilead Sciences OTC Anti-Infective Products Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Gilead Sciences OTC Anti-Infective Products Product Portfolio
  72. 8.12.5 Gilead Sciences Recent Developments
  73. 8.13 Cipla
  74. 8.13.1 Cipla Company Information
  75. 8.13.2 Cipla Business Overview
  76. 8.13.3 Cipla OTC Anti-Infective Products Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Cipla OTC Anti-Infective Products Product Portfolio
  78. 8.13.5 Cipla Recent Developments
  79. 8.14 Bausch Health
  80. 8.14.1 Bausch Health Company Information
  81. 8.14.2 Bausch Health Business Overview
  82. 8.14.3 Bausch Health OTC Anti-Infective Products Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Bausch Health OTC Anti-Infective Products Product Portfolio
  84. 8.14.5 Bausch Health Recent Developments
  85. 8.15 Astellas Pharma
  86. 8.15.1 Astellas Pharma Company Information
  87. 8.15.2 Astellas Pharma Business Overview
  88. 8.15.3 Astellas Pharma OTC Anti-Infective Products Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Astellas Pharma OTC Anti-Infective Products Product Portfolio
  90. 8.15.5 Astellas Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 OTC Anti-Infective Products Value Chain Analysis
  2. 9.1.1 OTC Anti-Infective Products Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 OTC Anti-Infective Products Production Mode & Process
  6. 9.2 OTC Anti-Infective Products Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 OTC Anti-Infective Products Distributors
  9. 9.2.3 OTC Anti-Infective Products Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst